Both in Pharmaceuticals
Zentalis Pharmaceuticals vs BridgeBio Oncology Therapeutics
Over the past year ZNTL returned +28.5% and BBOT returned −81.2%; their daily moves had a correlation of 0.21.
ZNTL +28.5% BBOT −81.2%Growth of $1, one year, split-adjusted
| Metric | ZNTL | BBOT |
|---|---|---|
| Price | $1.85 | $2.31 |
| Market cap | $175.1M | $185.2M |
| Today | −5.61% | −11.83% |
| 1 month | −26.6% | −40.6% |
| 6 months | −53.8% | −72.7% |
| Year to date | +37.0% | −81.5% |
| 1 year | +24.6% | −80.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $174.6M | $225.7M |
| Dividend yield | — | — |
| Volatility (60d) | 70.9% | 87.8% |
| Short % of float | 9.1% | 13.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).